|
24 Jan 2007 |
4SC nominates NFkB development candidate and presents new data
|
|
24 Jan 2007 |
Safety Monitoring Board Recommends Continuation of EntreMed's MKC-1 Phase 2 Breast Cancer Study
|
|
24 Jan 2007 |
Akorn, Inc. Announces Positive Phase III Pivotal Trial Results for Akten(R)
|
|
24 Jan 2007 |
New results from the ESPRIT trial confirm that dipyridamole plus aspirin is the treatment of choice for preventing recurrent stroke
|
|
24 Jan 2007 |
Stiefel Laboratories Receives FDA Approval Of Olux-E (Clobetasol Propionate) Foam, 0.05% For Treatment Of Psoriasis And Eczema
|
|
23 Jan 2007 |
Inovelon(R) recieves Marketing Authorization Approval from European Commission
|
|
23 Jan 2007 |
FDA Grants Chelsea Therapeutics Orphan Drug Designation for Droxidopa
|
|
23 Jan 2007 |
Ortho Biotech Seeks FDA Approval for DOXIL(R) in Combination with VELCADE(R) to Treat Relapsed/Refractory Multiple Myeloma
|
|
23 Jan 2007 |
Sirion Therapeutics Initiates Enrollment of Phase III Clinical Trials for the Treatment of Inflammation Following Ocular Surgery
|
|
23 Jan 2007 |
Infinity and MedImmune Provide Update On Phase I GIST Trial for IPI-504, a Novel Hsp90 Inhibitor
|
|
23 Jan 2007 |
Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
|
|
23 Jan 2007 |
MediciNova Initiates Phase II Clinical Trial for MN-305, a Novel Treatment for Insomnia
|
|
20 Jan 2007 |
S-1 Oral Anticancer Agent Improves Patients' Survival In Adjuvant Gastric Cancer Trial Versus Surgery Alone
|
|
20 Jan 2007 |
Pharmos Corporation Announces Clinical Data From Phase 2a Trial Of Cannabinor For Capsaicin-induced Pain; Drug Ineffective In Trial
|
|
20 Jan 2007 |
Penwest Begins Next Study in Development of Nalbuphine ER
|
|
20 Jan 2007 |
Bionovo Launches Pharmacokinetics Trial of Its Lead Menopause Drug Candidate, MF101
|
|
20 Jan 2007 |
Elbion AG Acquires Late-Stage Product Candidate From DrugAbuse Sciences, Inc. For Treatment Of Alcohol Dependence
|
|
19 Jan 2007 |
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
|
|
19 Jan 2007 |
Anesiva Announces Clinical Data From Phase 1 Trial of 1207
|
|
19 Jan 2007 |
Pfizer's Sutent is Granted Full Marketing Authorization for First-Line Use in Advanced Kidney Cancer in the European Union
|
|
18 Jan 2007 |
Genaera Corporation Announces Presentation Of Data On Trodusquemine Mechanism Of Action In Obesity
|
|
18 Jan 2007 |
Exforge(R) approved in Europe as powerful new blood pressure therapy combining two leading medications in a single pill
|
|
18 Jan 2007 |
Marketing Authorisation Granted for Tandemact (TM) (pioglitazone/glimepiride) for Type 2 Diabetes in Europe
|
|
18 Jan 2007 |
Barrier Therapeutics Announces Positive Phase 2a Data for Oral Hivenyl(TM) in the Treatment of Itch in Atopic Dermatitis
|
|
18 Jan 2007 |
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate From Bayer Schering Pharma
|
